Compositions and methods comprising digital signatures to predict response and resistance to targeted therapy and immunotherapy
US11505831B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2018 |
| Grant date | Nov 22, 2022 |
| Priority date | — |
| Expiry date | Feb 10, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to gene expression signatures that predict response and resistance to targeted therapy and immunotherapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.